Cargando…
Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes
BACKGROUND: Given that dysregulated metabolism has been recently identified as a hallmark of cancer biology, this study aims to establish and validate a prognostic signature of lung adenocarcinoma (LUAD) based on metabolism-related genes (MRGs). METHODS: The gene sequencing data of LUAD samples with...
Autores principales: | Wang, Zhihao, Embaye, Kidane Siele, Yang, Qing, Qin, Lingzhi, Zhang, Chao, Liu, Liwei, Zhan, Xiaoqian, Zhang, Fengdi, Wang, Xi, Qin, Shenghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050921/ https://www.ncbi.nlm.nih.gov/pubmed/33858449 http://dx.doi.org/10.1186/s12935-021-01915-x |
Ejemplares similares
-
Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma
por: Wang, Zhihao, et al.
Publicado: (2021) -
A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Zhihao, et al.
Publicado: (2021) -
Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia
por: Embaye, Kidane Siele, et al.
Publicado: (2021) -
A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
por: Wang, Zhihao, et al.
Publicado: (2022) -
An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)